◀ Back to FOS

CD28 — FOS

Text-mined interactions from Literome

Kempiak et al., J Immunol 1999 : Dominant negative versions of JNK kinase, c-Jun, and IKK beta interfered In CD3- plus CD28 induced CD28RE/AP-1 luciferase activity in Jurkat cells
Olsson et al., J Biol Chem 1999 : CTLA-4 ligation suppresses CD28 induced NF-kappaB and AP-1 activity in mouse T cell blasts
Coudronniere et al., Proc Natl Acad Sci U S A 2000 : Fourth, CD3/CD28 induced CD28RE/AP-1 activation and NF-kappaB nuclear translocation were blocked by a selective PKCtheta inhibitor
Li et al., EMBO J 2004 : Conversely, a SPAK-specific RNAi or a dominant negative SPAK mutant inhibited PKCtheta- and TCR/CD28 induced AP-1 , but not NF-kappaB, activation
Puzik et al., Cytokine 2012 (Infection) : While IGF-I did not influence apoptosis in our experimental setting, it led to a distinct decrease in anti-CD3/CD28 stimulated DNA binding activity of AP-1 and NF?B
Los et al., Biochem J 1994 : Inhibition of activation of transcription factor AP-1 by CD28 signalling in human T-cells
Edmead et al., J Immunol 1996 : Induction of activator protein (AP)-1 and nuclear factor-kappaB by CD28 stimulation involves both phosphatidylinositol 3-kinase and acidic sphingomyelinase signals ... Using selective inhibitors, we investigated the signaling pathways involved in the CD28 mediated induction of AP-1 and NF-kappaB
Gringhuis et al., Blood 1997 (Leukemia-Lymphoma, Adult T-Cell) : T-cell receptor (TCR)/CD3 engagement results in the activation of nuclear factor of activated T cells ( NFAT ), activator protein-1 (AP-1) , and nuclear factor kappaB (NFkappaB), whereas the CD28 responsive complex (CD28RC) is activated in response to the CD28 signal